辰欣药业(603367)今日涨停，全天换手率5.97%，成交额6.96亿元，振幅9.62%。龙虎榜数据显示，机构 净买入1.16亿元，沪股通净卖出5471.71万元，营业部席位合计净卖出921.40万元。 上交所公开信息显示，当日该股因日涨幅偏离值达11.18%上榜，机构专用席位净买入1.16亿元，沪股通 净卖出5471.71万元。 （文章来源：证券时报网） 资金流向方面，今日该股主力资金净流入8710.21万元，其中，特大单净流入6379.58万元，大单资金净 流入2330.63万元。近5日主力资金净流出1.15亿元。 8月28日公司发布的半年报数据显示，上半年公司共实现营业收入17.40亿元，同比下降15.97%，实现净 利润2.29亿元，同比下降15.23%。（数据宝） 辰欣药业9月3日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 机构专用 | 9548.60 | | | 买二 | 沪股通专用 | 5203.89 | | | 买三 | 开源证券股份有限公司西安西大街 ...

9月3日，A股市场整体下跌。 截至收盘，上证指数收报3813.56点，下跌1.16%，深证成指收报12472点，下跌0.65%，创业板指收报 2899.37点，上涨0.95%，北证50指数下跌1.49%。A股市场合计成交23961.02亿元，较上一交易日减少 5166.64亿元。 1. A股市场全天主力资金净流出479.12亿元 今日A股市场主力资金开盘净流出51.09亿元，尾盘净流出97.71亿元，全天净流出479.12亿元。 | | | 沪深两市近五日主力资金流向情况(亿元) | | | | --- | --- | --- | --- | --- | | 日期 | | | 净流入金额 开盘净流入 尾盘净流入 超大单净买入 | | | 2025-9-3 | -479.12 | -51.09 | -97. 71 | -202. 78 | | 2025-9-2 | -1196. 85 | -404. 51 | -93.05 | -719.76 | | 2025-9-1 | -364.22 | -183.69 | -41.39 | -131.29 | | 2025-8-29 | -527.66 | -222.09 ...

Summary of Key Points - On September 3, a total of 33 stocks were identified with institutional activity, with 15 stocks showing net buying and 18 stocks showing net selling [1] - The top three stocks with the highest net buying by institutions were Chenxin Pharmaceutical, Xiaocheng Technology, and Airo Energy, with net buying amounts of 116 million, 111 million, and 72.55 million respectively [1] - The top three stocks with the highest net selling by institutions were Yuanjie Technology, Chengdu Huamei, and Julun Intelligent, with net outflow amounts of 409 million, 112 million, and 98.8 million respectively [1]

Market Overview - On September 3, the Shanghai Composite Index fell by 1.16%, while the Shenzhen Component Index decreased by 0.65%. The ChiNext Index, however, rose by 0.95% [2] - A total of 53 stocks appeared on the "Dragon and Tiger List" due to significant trading activity, with the highest net inflow of funds recorded for Yanshan Technology (002195.SZ) at 639 million yuan [2][4] Stock Performance - Yanshan Technology saw a price increase of 9.07% with a turnover rate of 32.06%, and it accounted for 3.98% of the total trading volume [4] - The stock with the highest net outflow was Huasheng Tiancheng (600410.SH), which experienced a net sell-off of 371 million yuan and closed down by 9.09% with a turnover rate of 29.62% [4][6] Institutional Activity - On the same day, 25 stocks on the Dragon and Tiger List had institutional participation, with a total net purchase of 61.19 million yuan. Institutions net bought 13 stocks and net sold 12 stocks [6][11] - The stock with the highest net purchase by institutions was Chenxin Pharmaceutical (603367.SH), which rose by 10.02% and had a turnover rate of 5.97% [7][8] Northbound Capital Flow - Northbound capital participated in 21 stocks on the Dragon and Tiger List, with a total net purchase of 188 million yuan. The net purchase was highest for Yanshan Technology at 280 million yuan [11][15] - The stock with the highest net sell-off by northbound capital was Huasheng Tiancheng, with a net outflow of 270 million yuan [11] Notable Stocks - Other notable stocks with significant institutional and northbound capital activity included Su Da Weige, Airo Energy, and Shangneng Electric, which saw combined net purchases from both institutions and northbound capital [13][15] - Stocks like Julu Intelligent and Four Creation Electronics showed divergence in institutional and northbound capital actions, with institutions selling while northbound capital bought [13]

Summary of Key Points Core Viewpoint - On September 3rd, a total of 33 stocks appeared on the trading leaderboard, with 15 stocks showing net institutional buying and 18 stocks showing net institutional selling [2]. Institutional Buying - The top three stocks with the highest net institutional buying were: - Chenxin Pharmaceutical: Net buying amount of 116 million yuan, with a price increase of 10.02% [3]. - Xiaocheng Technology: Net buying amount of 111 million yuan, with a price decrease of 3.46% [3]. - Ailuo Energy: Net buying amount of 72.55 million yuan, with a price increase of 19.15% [3]. Institutional Selling - The top three stocks with the highest net institutional selling were: - Yuanjie Technology: Net outflow amount of 409 million yuan, with a price decrease of 13.01% [5]. - Chengdu Huamei: Net outflow amount of 111.63 million yuan, with a price increase of 14.97% [5]. - Giant Wheel Intelligent: Net outflow amount of 98.80 million yuan, with a price increase of 0.56% [5].

Group 1 - On September 3, a total of 33 stocks were involved with institutional investors, with 15 showing net buying and 18 showing net selling [1] - The top three stocks with net buying by institutions were Chenxin Pharmaceutical, Xiaocheng Technology, and Ailuo Energy, with net buying amounts of 116 million, 111 million, and 72.55 million respectively [1][2] - The top three stocks with net selling by institutions were Yuanjie Technology, Chengdu Huamei, and Julun Intelligent, with net outflow amounts of 409 million, 112 million, and 98.8 million respectively [1][3] Group 2 - The stock with the highest net buying was Chenxin Pharmaceutical, which saw a price increase of 10.02% [2] - Xiaocheng Technology experienced a price drop of 3.46% despite a significant net buying amount of 110.9 million [2] - Ailuo Energy had a notable price increase of 19.15% along with a net buying amount of 72.55 million [2] Group 3 - The stock with the highest net selling was Yuanjie Technology, which had a price drop of 13.01% and a net outflow of 409 million [3] - Chengdu Huamei saw a price increase of 14.97% but still experienced a net selling of 112 million [3] - Julun Intelligent had a slight price increase of 0.56% while facing a net outflow of 98.8 million [3]

证券之星消息，9月3日化学制药板块较上一交易日上涨1.39%，百利天恒领涨。当日上证指数报收于 3813.56，下跌1.16%。深证成指报收于12472.0，下跌0.65%。化学制药板块个股涨跌见下表： 从资金流向上来看，当日化学制药板块主力资金净流入9.41亿元，游资资金净流出8.69亿元，散户资金净 流出7145.32万元。化学制药板块个股资金流向见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 688506 | 百利天恒 | 410.00 | 13.39% | 2.17万 | | 8.12亿 | | 603367 | 辰欣药业 | 26.90 | 10.02% | 27.01万 | | 6.96亿 | | 600079 | 人福医药 | 22.57 | 9.99% | 142.47万 | | 31.61亿 | | 002020 | 京新药业 | 20.45 | 6.45% | 42.72万 | | 8.61亿 | | 688658 | 倪康药业 | 29.70 | ...

Market Overview - The Shanghai Composite Index closed at 3814.20 points, below the five-day moving average, with a decline of 1.14% [1] - The total trading volume of A-shares reached 1,878.28 billion yuan [1] Stocks Performance - A total of 139 A-shares broke through the five-day moving average today [1] - Stocks with significant deviation rates include: - Hailianxun (300277) with a deviation rate of 14.15%, closing up 20.03% [1] - Shoukai Co. (600376) with a deviation rate of 7.01%, closing up 9.85% [1] - Zhongchen Technology (603275) with a deviation rate of 6.97%, closing up 9.99% [1] - Other notable stocks with smaller deviation rates include: - Yunda Co. (300409) with a deviation rate of 6.32%, closing up 10.92% [1] - Hanzhong Precision (002158) with a deviation rate of 6.30%, closing up 10.00% [1] Detailed Stock Data - The following table summarizes the performance of selected stocks that broke through the five-day moving average: | Stock Code | Stock Name | Daily Change (%) | Turnover Rate (%) | Five-Day MA (yuan) | Latest Price (yuan) | Deviation Rate (%) | | --- | --- | --- | --- | --- | --- | --- | | 300277 | Hailianxun | 20.03 | 24.96 | 13.54 | 15.46 | 14.15 | | 600376 | Shoukai Co. | 9.85 | 6.33 | 2.71 | 2.90 | 7.01 | | 603275 | Zhongchen Technology | 9.99 | 10.43 | 50.42 | 53.94 | 6.97 | | 002067 | Jingxing Paper | 10.00 | 15.98 | 4.34 | 4.62 | 6.55 | | 300409 | Yunda Co. | 10.92 | 20.47 | 22.07 | 23.47 | 6.32 | | 002158 | Hanzhong Precision | 10.00 | 3.58 | 25.04 | 26.62 | 6.30 | | 688108 | Sainuo Medical | 9.10 | 11.70 | 33.29 | 35.13 | 5.54 | | 603283 | Saiteng Co. | 7.32 | 9.18 | 41.65 | 43.85 | 5.27 | | 300655 | Jingrui Materials | 7.83 | 14.56 | 12.30 | 12.94 | 5.24 | | 300905 | Baolidai | 9.29 | 12.54 | 32.92 | 34.57 | 5.02 | | 603992 | Songlin Technology | 6.80 | 1.51 | 29.63 | 31.10 | 4.98 | | 688717 | Ailuo Energy | 9.04 | 5.60 | 68.52 | 71.80 | 4.78 | | 002549 | Kaimeteqi | 8.68 | 17.83 | 16.53 | 17.28 | 4.52 | | 603367 | Chenxin Pharmaceutical | 10.02 | 5.75 | 25.75 | 26.90 | 4.45 | | 301491 | Hansang Technology | 6.43 | 26.20 | 66.30 | 69.07 | 4.18 | | 300303 | Jufei Optoelectronics | 5.04 | 10.31 | 6.84 | 7.08 | 3.48 | | 601869 | Changfei Optical Fiber | 10.00 | 5.24 | 88.00 | 91.06 | 3.47 | | 600699 | Junsheng Electric | 4.33 | 6.13 | 21.26 | 21.95 | 3.26 | | 002531 | Tienswind Energy | 5.37 | 2.16 | 6.86 | 7.07 | 3.03 | | 301182 | Kaiwang Technology | 6.37 | 9.05 | 38.56 | 39.73 | 3.02 [2]

Group 1 - The company held a half-year performance and cash dividend briefing on September 2, 2025, attended by key executives including the chairman and financial director [1][2]. - The company reported a revenue of 3,981,572,232.95 yuan for 2024, a decrease of 10.77% compared to 2023's revenue of 4,462,348,636.07 yuan [4]. - For the first half of 2025, the company achieved a revenue of 1.74 billion yuan, a decrease of 15.97% year-on-year, with a net profit attributable to shareholders of 229 million yuan, down 15.23% [6]. Group 2 - The company aims to enhance its core competitiveness through innovation and quality, focusing on high-quality development and optimizing its product mix to meet market demands [2][3]. - The company has over 100 ongoing research projects, targeting various therapeutic areas including oncology and cardiovascular diseases, to build a complementary product portfolio [5]. - The company emphasizes a diversified sales model, leveraging both policy responsiveness and resource integration to maintain revenue and profit sustainability amid industry price pressures [6][7]. Group 3 - The company has implemented a comprehensive employee training program to ensure high-quality development, focusing on talent cultivation and management [7]. - The company has established an audit committee for internal control and risk management, ensuring effective oversight of its subsidiaries [8]. - The company's 2020 equity incentive plan has been fully implemented [9].

证券代码：603367 证券简称：辰欣药业 公告编号：2025-049 辰欣药业股份有限公司 关于 2025 年半年度业绩暨现金分红说明会 召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 辰欣药业股份有限公司（以下简称"公司"或"辰欣药业"）于 2025 年 9 月 2 日上午 9:30-11:30 在上海证券交易所上证路演中心（网址：http://roads how.sseinfo.com）, 以网络文字互动方式召开了公司 2025 年半年度业绩暨现金 分红说明会。就投资者普遍关心和关注的问题进行了互动交流沟通。现将召开情 况公告如下： 一、业绩说明会的召开情况 公司于 2025 年 8 月 28 日在上海证券交易所网站（www.sse.com.cn）和信息 披露指定媒体披露了《辰欣药业股份有限公司关于召开 2025 年半年度业绩暨现 金分红说明会的公告》（公告编号：2025-046）。 2025 年 9 月 2 日上午 9:30-11:30，董事长、总经理杜振新先生、独立董事 王唯佳女士和财务总监兼董事会秘 ...